scispace - formally typeset
I

Ian O. Ellis

Researcher at University of Nottingham

Publications -  1071
Citations -  84964

Ian O. Ellis is an academic researcher from University of Nottingham. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 126, co-authored 1051 publications receiving 75435 citations. Previous affiliations of Ian O. Ellis include Mansoura University & Curie Institute.

Papers
More filters
Journal ArticleDOI

Best Practice No 176 : Updated recommendations for HER2 testing in the UK

TL;DR: A two phase testing algorithm based on first line immunocytochemistry evaluation and second line fluorescence in situ hybridization assessment of borderline cases is recommended in this article, where emphasis is placed on the standardisation of methodology and assessment and strategies to achieve high quality performance.
Journal ArticleDOI

Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates.

TL;DR: A review of the literature indicated variable underestimation rates for breast core-needle biopsy (CNB) based on generally small series was 27.7% (95% confidence interval [95% CI], 24.5-30.9% as mentioned in this paper.
Journal ArticleDOI

Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It Is the Predominant Method of Vascular Invasion in Breast Cancer and Has Important Clinical Consequences

TL;DR: In conclusion, VI in breast cancer is predominantly of lymph vessels and is a powerful independent prognostic factor, which is associated with risk of recurrence and death from the disease.
Journal ArticleDOI

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

TL;DR: Even in these patients with tumours of excellent prognosis, LR after conservative surgery without adjuvant therapy was still very high and was reduced to a similar extent by either radiotherapy or tamoxifen but to a greater extent by the receipt of both treatments.